Loading clinical trials...
Loading clinical trials...
It is estimated that 30% of individuals with Major Depressive Disorder (MDD) fail to respond to conventional antidepressant medication which accounts for over 1 million Canadians in their lifetime. Tr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Unity Health Toronto
Collaborators
NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression
NCT06731621 · Treatment Resistant Depression, Autism Spectrum Disorder
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT04041479 · Treatment Resistant Depression, Major Depressive Disorder
NCT06524830 · Treatment Resistant Depression
Unity Health Toronto
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions